The Oncology Institute, Inc.
TOI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 21.3% | 28.4% | 24.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 13.7% | 18.4% | 20.6% | 20.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13.7% | -16.7% | -26.8% | -20.7% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -16.4% | -25.6% | 0.1% | -5.4% |
| EPS Diluted | -0.71 | -0.92 | -0.21 | -0.16 |
| % Growth | 22.8% | -338.1% | -31.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |